Seminars in Oncology
Volume 34, Supplement 3 , Pages S17-S22, April 2007

Biomarker Studies and Other Difficult Inferential Problems: Statistical Caveats

  • Donald A. Berry

      Affiliations

    • Dr Berry serves on the Biostatistics Advisory Board for Bristol-Myers Squibb. He has served as a consultant to Eli Lilly and Company and Novartis Pharmaceuticals, and has received honoraria from AstraZeneca Pharmaceuticals LP and Pfizer Inc.
    • Corresponding Author InformationAddress correspondence to Donald A. Berry, PhD, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.

The University of Texas, M. D. Anderson Cancer Center, Houston, TX.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(07)00068-1

doi:10.1053/j.seminoncol.2007.03.014

Seminars in Oncology
Volume 34, Supplement 3 , Pages S17-S22, April 2007

Article Tools

* Image Usage & Resolution